Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort

被引:62
作者
Tikk, K. [1 ]
Sookthai, D. [1 ]
Johnson, T. [1 ]
Rinaldi, S. [2 ]
Romieu, I. [2 ]
Tjonneland, A. [3 ]
Olsen, A. [3 ]
Overvad, K. [4 ]
Clavel-Chapelon, F. [5 ,6 ,7 ]
Baglietto, L. [8 ,9 ]
Boeing, H. [10 ]
Trichopoulou, A. [11 ,12 ]
Lagiou, P. [11 ,13 ,14 ]
Trichopoulos, D. [12 ,13 ,14 ]
Palli, D. [15 ]
Pala, V. [16 ]
Tumino, R. [17 ,18 ]
Rosso, S. [19 ]
Panico, S. [20 ]
Agudo, A. [21 ]
Menendez, V. [22 ]
Sanchez, M. -J. [23 ,24 ]
Amiano, P. [24 ,25 ]
Huerta Castano, J. M. [24 ,26 ]
Ardanaz, E. [24 ,27 ]
Bueno-de-Mesquita, H. B. [28 ,29 ,30 ]
Monninkhof, E. [31 ]
Onland-Moret, C. [31 ]
Andersson, A. [32 ]
Sund, M. [33 ]
Weiderpass, E. [34 ,35 ,36 ,37 ]
Khaw, K. -T. [38 ]
Key, T. J. [39 ]
Travis, R. C. [39 ]
Gunter, M. J. [30 ]
Riboli, E. [30 ]
Dossus, L. [5 ,6 ,7 ]
Kaaks, R. [1 ]
机构
[1] German Canc Res Ctr DKFZ Heidelberg, Div Canc Epidemiol, D-69120 Heidelberg, Germany
[2] Int Agcy Res Canc, Sect Nutr & Metab, F-69372 Lyon, France
[3] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[4] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark
[5] INSERM, Nutr Hormones & Womens Hlth Team, Ctr Res Epidemiol & Populat Hlth CESP, Villejuif, France
[6] Univ Paris 11, UMRS, Villejuif, France
[7] IGR, Villejuif, France
[8] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia
[9] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia
[10] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Potsdam, Nuthetal, Germany
[11] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece
[12] Hellen Hlth Fdn, Athens, Greece
[13] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[14] Acad Athens, Bur Epidemiol Res, Athens, Greece
[15] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy
[16] Natl Tumor Inst IRCCS, Epidemiol & Prevent Unit, Milan, Italy
[17] Civ MP Arezzo Hosp ASP, Canc Registry, Ragusa, Italy
[18] Civ MP Arezzo Hosp ASP, Histopathol Unit, Ragusa, Italy
[19] Ctr Epidemiol & Prevent Oncol Piedmont, Piedmont Canc Registry, Turin, Italy
[20] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy
[21] IDIBELL, Catalan Inst Oncol ICO, Unit Nutr Environm & Canc, Barcelona, Spain
[22] Publ Hlth Directorate, Asturias, Spain
[23] Andalusian Sch Publ Hlth, Granada Canc Registry, Granada, Spain
[24] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain
[25] Basque Reg Hlth Dept, Publ Hlth Div Gipuzkoa, San Sebastian, Spain
[26] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain
[27] Navarre Publ Hlth Inst, Pamplona, Spain
[28] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
[29] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[30] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England
[31] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands
[32] Umea Univ, Dept Radiat Sci, Umea, Sweden
[33] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden
[34] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway
[35] Canc Registry Norway, Dept Res, Oslo, Norway
[36] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[37] Soc Publ Hlth, Helsinki, Finland
[38] Univ Cambridge, Sch Clin Med, Cambridge, England
[39] Univ Oxford, Canc Epidemiol Unit, Oxford, England
基金
英国医学研究理事会;
关键词
breast cancer; prolactin levels; hormone replacement therapy; estrogen receptor; progesterone receptor; prospective cohort; PLASMA PROLACTIN; RECEPTOR; HORMONES; REPRODUCIBILITY;
D O I
10.1093/annonc/mdu150
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Experimental and epidemiological evidence suggests that prolactin might play a role in the etiology of breast cancer. We analyzed the relationship of prediagnostic circulating prolactin levels with the risk of breast cancer by menopausal status, use of postmenopausal hormone replacement therapy (HRT) at blood donation, and by estrogen and progesterone receptor status of the breast tumors. Conditional logistic regression was used to analyze the data from a case-control study nested within the prospective European EPIC cohort, including 2250 invasive breast cancer and their matched control subjects. Statistically significant heterogeneity in the association of prolactin levels with breast cancer risk between women who were either pre- or postmenopausal at the time of blood donation was observed (P-het = 0.04). Higher serum levels of prolactin were associated with significant increase in the risk of breast cancer among postmenopausal women [odds ratio (OR)(Q4-Q1) = 1.29 (95% confidence interval, CI, 1.05-1.58), P-trend = 0.09]; however, this increase in risk seemed to be confined to women who used postmenopausal HRT at blood donation [ORQ4-Q1 = 1.45 (95% CI 1.08-1.95), P-trend = 0.01], whereas no statistically significant association was found for the non-users of HRT [ORQ4-Q1 = 1.11 (95%CI 0.83-1.49), P-trend = 0.80] (P-het = 0.08). Among premenopausal women, a statistically non-significant inverse association was observed [ORQ4-Q1 = 0.70 (95% CI 0.48-1.03), P-trend = 0.16]. There was no heterogeneity in the prolactin-breast cancer association by hormone receptor status of the tumor. Our study indicates that higher circulating levels of prolactin among the postmenopausal HRT users at baseline may be associated with increased breast cancer risk.
引用
收藏
页码:1422 / 1428
页数:7
相关论文
共 50 条
[31]   Serum isoflavones and lignans and odds of breast cancer in pre- and postmenopausal Chinese women [J].
Feng, Xiao-Li ;
Ho, Suzanne C. ;
Zhan, Xiao-Xia ;
Zuo, Luo-Shi-Yuan ;
Mo, Xiong-Fei ;
Zhang, Xin ;
Abulimiti, Alinuer ;
Huang, Chu-Yi ;
Zhang, Cai-Xia .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (04) :413-422
[32]   Air pollution and green spaces in relation to breast cancer risk among pre and postmenopausal women: A mega cohort from Catalonia [J].
Terre-Torras, Isaura ;
Recalde, Martina ;
Diaz, Yesika ;
de Bont, Jeroen ;
Bennett, Matthew ;
Aragon, Maria ;
Cirach, Marta ;
O'Callaghan-Gordo, Cristina ;
Nieuwenhuijsen, Mark J. ;
Duarte-Salles, Talita .
ENVIRONMENTAL RESEARCH, 2022, 214
[33]   Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women [J].
Baglietto, Laura ;
Severi, Gianluca ;
English, Dallas R. ;
Krishnan, Kavitha ;
Hopper, John L. ;
McLean, Catriona ;
Morris, Howard A. ;
Tilley, Wayne D. ;
Giles, Graham G. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) :492-502
[34]   Alcohol consumption trajectories and risk of breast cancer among postmenopausal women: a Danish cohort study [J].
Antoniussen, Christian S. ;
Proust-Lima, Cecile ;
Ibsen, Daniel B. ;
Olsen, Anja ;
Overvad, Kim ;
Tjonneland, Anne ;
Ferrari, Pietro ;
Dahm, Christina C. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2024, 39 (12) :1353-1362
[35]   Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study [J].
Suzuki, Reiko ;
Rylander-Rudqvist, Tove ;
Ye, Weimin ;
Saji, Shigehira ;
Wolk, Alicja .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) :1683-1689
[36]   Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women-a case-control study [J].
Pacholczak, Renata ;
Klimek-Piotrowska, Wieslawa ;
Kuszmiersz, Piotr .
JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY, 2016, 35
[37]   Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer [J].
Manuel Martinez-Martos, Jose ;
del Pilar Carrera-Gonzalez, Maria ;
Duenas, Basilio ;
Dolores Mayas, Maria ;
Jesus Garcia, Maria ;
Jesus Ramirez-Exposito, Maria .
BREAST, 2011, 20 (05) :444-447
[38]   Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women [J].
Lim, Vanessa W. ;
Li, Jun ;
Gong, Yinhan ;
Jin, Aizhen ;
Yuan, Jian-Min ;
Yong, Eu Leong ;
Koh, Woon-Puay .
ENDOCRINE-RELATED CANCER, 2014, 21 (02) :263-273
[39]   Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies [J].
Key, T. J. ;
Appleby, P. N. ;
Reeves, G. K. ;
Roddam, A. W. ;
Helzlsouer, K. J. ;
Alberg, A. J. ;
Rollison, D. E. ;
Dorgan, J. F. ;
Brinton, L. A. ;
Overvad, K. ;
Kaaks, R. ;
Trichopoulou, A. ;
Clavel-Chapelon, F. ;
Panico, S. ;
Duell, E. J. ;
Peeters, P. H. M. ;
Rinaldi, S. ;
Riboli, E. ;
Fentiman, I. S. ;
Dowsett, M. ;
Manjer, J. ;
Lenner, P. ;
Hallmans, G. ;
Baglietto, L. ;
English, D. R. ;
Giles, G. G. ;
Hopper, J. L. ;
Severi, G. ;
Morris, H. A. ;
Koenig, K. ;
Zeleniuch-Jacquotte, A. ;
Arslan, A. A. ;
Toniolo, P. ;
Shore, R. E. ;
Krogh, V. ;
Micheli, A. ;
Berrino, F. ;
Muti, P. ;
Barrett-Connor, E. ;
Laughlin, G. A. ;
Kabuto, M. ;
Akiba, S. ;
Stevens, R. G. ;
Neriishi, K. ;
Land, C. E. ;
Cauley, J. A. ;
Lui, Li Yung ;
Cummings, Steven R. ;
Gunter, M. J. ;
Rohan, T. E. .
BRITISH JOURNAL OF CANCER, 2011, 105 (05) :709-722